Share-Based Compensation Share-Based Compensation (Tables)
|
12 Months Ended |
Dec. 27, 2025 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Share-based Payment Arrangement, Cost by Plan [Table Text Block] |
The following table summarizes our total share-based compensation expense, which is primarily recorded in selling, general and administrative expenses, and excess tax benefits recognized: | | | | | | | | | | | | | | | | | | | 2025 | | 2024 | | 2023 | | Share-based compensation expense - equity awards | $ | 288 | | | $ | 362 | | | $ | 380 | | | Share-based compensation expense - liability awards | 13 | | | 7 | | | 19 | | | Restructuring charges | (8) | | | (5) | | | (1) | | | Total | $ | 293 | | | $ | 364 | | | $ | 398 | | | Income tax benefits recognized in earnings related to share-based compensation | $ | 53 | | | $ | 68 | | | $ | 73 | | Excess tax benefits related to share-based compensation | $ | 3 | | | $ | 33 | | | $ | 36 | |
|
| Schedule Of Weighted-Average Black-Scholes Fair Value Assumptions |
Our weighted-average Black-Scholes fair value assumptions are as follows: | | | | | | | | | | | | | | | | | | | 2025 | | 2024 | | 2023 | | Expected life | 7 years | | 7 years | | 7 years | | Risk-free interest rate | 4.1 | % | | 4.2 | % | | 4.2 | % | | Expected volatility | 16 | % | | 16 | % | | 16 | % | | Expected dividend yield | 3.5 | % | | 2.9 | % | | 2.7 | % |
|
| Share-based Payment Arrangement, Option, Activity [Table Text Block] |
A summary of our stock option activity for the year ended December 27, 2025 is as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Options(a) | | Weighted-Average Exercise
Price Per Unit | | Weighted-Average Contractual
Life Remaining
(years) | | Aggregate Intrinsic Value(a) | Outstanding at December 28, 2024 | 11,055 | | | $ | 143.88 | | | | | | | Granted | 1,804 | | | $ | 150.28 | | | | | | | Exercised | (896) | | | $ | 108.72 | | | | | | | Forfeited/expired | (642) | | | $ | 163.52 | | | | | | Outstanding at December 27, 2025 | 11,321 | | | $ | 146.60 | | | 6.0 | | $ | 100,992 | | Exercisable at December 27, 2025 | 6,279 | | | $ | 134.10 | | | 4.2 | | $ | 98,385 | | Expected to vest as of December 27, 2025 | 4,793 | | | $ | 162.45 | | | 8.2 | | $ | 2,468 | |
(a)In thousands.
|
| Our RSU and PSU Activity |
A summary of our RSU and PSU activity for the year ended December 27, 2025 is as follows: | | | | | | | | | | | | | | | | | | | | | | | |
| RSUs/PSUs(a) | | Weighted-Average
Grant-Date Fair Value Per Unit | | Weighted-Average Contractual Life
Remaining (years) | | Aggregate Intrinsic Value(a) | Outstanding at December 28, 2024 | 5,366 | | | $ | 166.09 | | | | | | | Granted | 2,199 | | | $ | 153.22 | | | | | | | Converted | (1,849) | | | $ | 163.78 | | | | | | | Forfeited | (607) | | | $ | 163.47 | | | | | | Outstanding at December 27, 2025 (b) | 5,109 | | | $ | 161.72 | | | 1.3 | | $ | 734,635 | | Expected to vest as of December 27, 2025 (c) | 4,411 | | | $ | 162.11 | | | 1.2 | | $ | 634,185 | |
(a)In thousands. Outstanding awards are disclosed at target. (b)The outstanding PSUs for which the vesting period has not ended as of December 27, 2025, at the threshold, target and maximum award levels were zero, 0.7 million and 1.4 million, respectively. (c)Represents the number of outstanding awards expected to vest, including estimated performance adjustments on all outstanding PSUs as of December 27, 2025.
|
| Schedule of Liability Award Vested and Expected to Vest [Table Text Block] |
A summary of our long-term cash activity for the year ended December 27, 2025 is as follows: | | | | | | | | | | | | | | | | | | | Long-Term Cash Award(a) | | Balance Sheet Date Fair Value(b) | | Contractual Life Remaining
(years) | Outstanding at December 28, 2024 | $ | 53,970 | | | | | | | Granted | 21,636 | | | | | | | Vested | (11,274) | | | | | | | Forfeited | (7,297) | | | | | | Outstanding at December 27, 2025 (c) | $ | 57,035 | | | $ | 36,064 | | | 1.2 | Expected to vest as of December 27, 2025 | $ | 54,169 | | | $ | 33,597 | | | 1.2 |
(a)In thousands, disclosed at target. (b)In thousands, based on the most recent valuation as of December 27, 2025. (c)The outstanding awards for which the vesting period has not ended as of December 27, 2025, at the threshold, target and maximum award levels based on the achievement of its market conditions were zero, $57 million and $114 million, respectively.
|
| Other Share-Based Compensation Data |
The following is a summary of other share-based compensation data: | | | | | | | | | | | | | | | | | | | 2025 | | 2024 | | 2023 | | Stock Options | | | | | | Total number of options granted (a) | 1,804 | | | 2,034 | | | 2,162 | | | Weighted-average grant-date fair value per unit of options granted | $ | 21.13 | | | $ | 27.29 | | | $ | 29.81 | | Total intrinsic value of options exercised (a) | $ | 35,558 | | | $ | 99,388 | | | $ | 100,209 | | Total grant-date fair value of options vested (a) | $ | 32,506 | | | $ | 14,759 | | | $ | 11,830 | | | RSUs/PSUs | | | | | | Total number of RSUs/PSUs granted (a) | 2,199 | | | 2,348 | | | 2,151 | | | Weighted-average grant-date fair value per unit of RSUs/PSUs granted | $ | 153.22 | | | $ | 164.25 | | | $ | 171.11 | | Total intrinsic value of RSUs/PSUs converted (a) | $ | 299,958 | | | $ | 372,612 | | | $ | 396,123 | | Total grant-date fair value of RSUs/PSUs vested (a) | $ | 300,591 | | | $ | 280,673 | | | $ | 286,605 | | | | | | | | | | | | | | | | | | | |
(a)In thousands.
|